• Home
  • PR

PR

News

게시물 상세
OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA
Date : 2021-06-14     View : 464

OliX Pharmaceuticals Subsidiary mCureX Announces Business Agreements to Advance Development of mRNA Vaccines and Therapeutics

 

Learn more: https://finance.yahoo.com/news/olix-pharmaceuticals-subsidiary-mcurex-announces-120000163.html

 

Source _ OliX Pharmaceuticals

Prev OliX Signs Agreement with LGC Biosearch Technologies for the Treatment of Androgenic Alopecia
Next OliX Receives Notice of Allowance from US Patent and Trademark Office for Improved Technology